Circulating tumor cells in early breast cancer: A connection with vascular invasion

Cancer Letters

Volumn 367, Issue 1, 2015, Pages 43-48

  Maltoni, Roberta ^a   Fici, Pietro ^a   Amadori, Dino ^a   Gallerani, Giulia ^b   Cocchi, Claudia ^b   Zoli, Martina ^c   Rocca, Andrea ^a   Cecconetto, Lorenzo ^a   Folli, Secondo ^d   Scarpi, Emanuela ^a   Serra, Patrizia ^a   Fabbri, Francesco ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

CTCs; DEPArray ; Early breast cancer; Vascular invasion

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER HORMONE THERAPY; CELL INVASION; CELL PROLIFERATION; CELL SELECTION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; ELECTROPHORESIS; FEASIBILITY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INCIDENCE; LYMPH VESSEL METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; SEGMENTAL MASTECTOMY; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; BLOOD; BLOOD VESSEL; BREAST NEOPLASMS; CANCER STAGING; CELL SEPARATION; DRUG EFFECTS; EVALUATION STUDY; FEMALE; LYMPH NODE METASTASIS; MASTECTOMY; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PROCEDURES; TIME; TREATMENT OUTCOME; TUMOR EMBOLISM; TUMOR INVASION;

ANTIGENS, NEOPLASM; BLOOD VESSELS; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL PROLIFERATION; CELL SEPARATION; CHEMOTHERAPY, ADJUVANT; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MCF-7 CELLS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84939263879     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.06.020     Document Type: Article

References (38)

1. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No. 11 [Internet] Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr.
2. DeSantis C.E., Lin C.C., Mariotto A.B., Siegel R.L., Stein K.D., Kramer J.L., et al. Cancer treatment and survivorship statistics. CA Cancer J. Clin 2014, 64(2014):252-271. 10.3322/caac.21235.
3. Malvezzi M., Bertuccio P., Rosso T., Rota M., Levi F., La Vecchia C., et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?. Ann. Oncol 2015, 26:779-786. 10.1093/annonc/mdv001.
4. Swaby R.F., Cristofanilli M. Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med 2011, 9:43. 10.1186/1741-7015-9-43.
5. Wan L., Pantel K., Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med 2013, 19:1450-1464. 10.1038/nm.3391.
6. Joosse S.A., Gorges T.M., Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol. Med 2014, 7:1-11. 10.15252/emmm.201303698.
7. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med 2004, 351:781-791.
8. Nolé F., Munzone E., Zorzino L., Minchella I., Salvatici M., Botteri E., et al. Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann. Oncol 2008, 19:891-897.
9. Liu M.C., Mego M., Nakamura S., Nole F., Pierga J., Toi M., et al. Clinical validity of circulating tumor cell (CTC) enumeration in 841 subjects with metastatic breast cancer (MBC). J. Clin. Oncol 2011, 29:10592.
10. Bidard F.C., Peeters D.J., Fehm T., Nolé F., Gisbert-Criado R., Mavroudis D., et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014, 15:406-414. 10.1016/S1470-2045(14)70069-5.
11. Bidard F.C., Mathiot C., Delaloge S., Brain E., Giachetti S., de Cremoux P., et al. Single circulating tumor cell detection and overall survival in non-metastatic breast cancer. Ann. Oncol 2010, 21:729-733. 10.1093/annonc/mdp391.
12. Schindlbeck C., Andergassen U., Hofmann S., Jückstock J., Jeschke U., Sommer H., et al. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients. J. Cancer Res. Clin. Oncol 2013, 139:1055-1062. 10.1007/s00432-013-1418-0.
13. Rack B., Andergassen U., Janni W., Neugebauer J. CTCs in primary breast cancer (I). Recent Results Cancer Res 2012, 195:179-185. 10.1007/978-3-642-28160-0_16.
14. Graves H., Czerniecki B.J. Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Patholog. Res. Int 2011, 2011:621090. 10.4061/2011/621090.
15. Lucci A., Hall C.S., Lodhi A.K., Bhattacharyya A., Anderson A.E., Xiao L., et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 2012, 13:688-695. 10.1016/S1470-2045(12)70209-7.
16. Zhang L., Riethdorf S., Wu G., Wang T., Yang K., Peng G., et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin. Cancer Res 2012, 18:5701-5710. 10.1158/1078-0432.CCR-12-1587.
17. Rack B., Schindlbeck C., Jückstock J., Andergassen U., Hepp P., Zwingers T., et al. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J. Natl Cancer Inst 2014, 106. dju066 [pii]. 10.1093/jnci/dju066.
18. Lang J.E., Mosalpuria K., Cristofanilli M., Krishnamurthy S., Reuben J., Singh B., et al. HER2 Status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res. Treat 2009, 113:501-507. 10.1007/s10549-008-9951-2.
19. Krishnamurthy S., Cristofanilli M., Singh B., Reuben J., Gao H., Cohen E.N., et al. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer 2010, 116:3330-3337. 10.1002/cncr.25145.
20. Rack B.K., Schindlbeck C., Andergassen U., Schneeweiss A., Zwingers T., Lichtenegger W., et al. Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: the SUCCESS trial. J. Clin. Oncol 2010, 28(15s). suppl; abstr 1003.
21. Sandri M.T., Zorzino L., Cassatella M.C., Bassi F., Luini A., Casadio C., et al. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann. Surg. Oncol 2010, 17:1539-1545. 10.1245/s10434-010-0918-2.
22. Raynor M.P., Stephenson S.A., Pittman K.B., Walsh D.C., Henderson M.A., Dobrovic A. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR. J. Hematol. Oncol 2009, 2:24. 10.1186/1756-8722-2-24.
23. Fabbri F., Carloni S., Zoli W., Ulivi P., Gallerani G., Fici P., et al. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 2013, 335:225-231. 10.1016/j.canlet.2013.02.015.
24. Franken B., de Groot M.R., Mastboom W.J., Vermes I., van der Palen J., Tibbe A.G., et al. Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res 2012, 14:R133. 10.1186/bcr3333.
25. Smirnov D.A., Zweitzig D.R., Foulk B.W., Miller M.C., Doyle G.V., Pienta K.J., et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005, 65:4993-4997.
26. Rakha E.A., Martin S., Lee A.H., Morgan D., Pharoah P.D., Hodi Z., et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer 2012, 118:3670-3680. 10.1002/cncr.26711.
27. Podsypanina K., Du Y.C., Jechlinger M., Beverly L.J., Hambardzumyan D., Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321:1841-1844. 10.1126/science.1161621.
28. Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361. 10.1016/j.cell.2011.11.025.
29. Hüsemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68. 10.1016/j.ccr.2007.12.003.
30. Viret F., Chabannon C., Sainty D., Genre D., Gonçalves A., Arnoulet C., et al. Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy. Bone Marrow Transplant 2003, 32:1059-1064.
31. Bouchard G., Bouvette G., Therriault H., Bujold R., Saucier C., Paquette B. Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases. Br. J. Cancer 2013, 109:1829-1838. 10.1038/bjc.2013.502.
32. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444. 10.1038/nature07205.
33. Madani I., De Neve W., Mareel M. Does ionizing radiation stimulate cancer invasion and metastasis?. Bull. Cancer 2008, 95:292-300. 10.1684/bdc.2008.0598.
34. Kallergi G., Konstantinidis G., Markomanolaki H., Papadaki M.A., Mavroudis D., Stournaras C., et al. Apoptotic circulating tumor cells in early and metastatic breast cancer patients. Mol. Cancer Ther 2013, 12:1886-1895. 10.1158/1535-7163.MCT-12-1167.
35. Rossi E., Basso U., Celadin R., Zilio F., Pucciarelli S., Aieta M., et al. M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin. Cancer Res 2010, 16:5233-5243. 10.1158/1078-0432.CCR-10-1449.
36. Barrière G., Tartary M., Rigaud M. Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells. ISRN Oncol 2012, 2012:382010. 10.5402/2012/382010.
37. Lianidou E.S. Circulating tumor cell isolation: a marathon race worth running. Clin. Chem 2014, 60:287-289. 10.1373/clinchem.2013.216010.
38. Grover P.K., Cummins A.G., Price T.J., Roberts-Thomson I.C., Hardingham J.E. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann. Oncol 2014, 25(8):1506-1516. 10.1093/annonc/mdu018.